INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 279 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $758,948 | -7.2% | 24,003 | +19.9% | 0.00% | 0.0% |
| Q2 2023 | $817,639 | +2.9% | 20,025 | -6.2% | 0.00% | 0.0% |
| Q1 2023 | $794,463 | +12.0% | 21,348 | +5.1% | 0.00% | 0.0% |
| Q4 2022 | $709,487 | +67.7% | 20,314 | +167.6% | 0.00% | 0.0% |
| Q3 2022 | $423,000 | +8.2% | 7,592 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $391,000 | -52.7% | 7,577 | -12.4% | 0.00% | -50.0% |
| Q1 2022 | $826,000 | -18.5% | 8,645 | +1.0% | 0.00% | 0.0% |
| Q4 2021 | $1,013,000 | -8.0% | 8,557 | +4.4% | 0.00% | 0.0% |
| Q3 2021 | $1,101,000 | -35.9% | 8,197 | -22.6% | 0.00% | -50.0% |
| Q2 2021 | $1,717,000 | +80.0% | 10,586 | -11.0% | 0.00% | +100.0% |
| Q1 2021 | $954,000 | +58.5% | 11,897 | +7.3% | 0.00% | 0.0% |
| Q4 2020 | $602,000 | +215.2% | 11,087 | +15.2% | 0.00% | +100.0% |
| Q3 2020 | $191,000 | -8.2% | 9,621 | -2.9% | 0.00% | 0.0% |
| Q2 2020 | $208,000 | +23.8% | 9,912 | -26.8% | 0.00% | 0.0% |
| Q1 2020 | $168,000 | – | 13,539 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HIMENSION CAPITAL (SINGAPORE) PTE. LTD. | 1,216,340 | $62,958,000 | 7.04% |
| Discovery Value Fund | 584,483 | $30,253,000 | 6.33% |
| MPM BioImpact LLC | 299,409 | $15,497,000 | 4.30% |
| ARK Investment Management | 9,514,580 | $439,003,000 | 2.60% |
| Elmwood Wealth Management, Inc. | 67,899 | $3,514,000 | 2.00% |
| Nikko Asset Management Americas, Inc. | 2,781,136 | $141,143,000 | 1.74% |
| Avidity Partners Management LP | 1,125,194 | $58,240,000 | 1.34% |
| Merlin Capital, Inc | 12,174 | $630,000 | 1.26% |
| Atlas Venture Associates IX, LLC | 10,000 | $518,000 | 1.18% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 111,440 | $5,768,000 | 1.16% |